PJPInvesco Pharmaceuticals ETF

Grow my money20y track recordRanked #1,031 of 2,960 in this goal

Seeks to track the investment results of the Dynamic Pharmaceutical Intellidex Index.

By Invesco · Launched 2005

Annual Cost

0.57%

#2,891 of 5,562 · average

Fund Size

$341M

#1,859 of 5,562 · large

Return (1Y)Goal

+38.9%

Track Record

20 years

#232 of 5,562 · established

Performance

Total-return NAV · USD

Growth of $10,000

$14,299+43.0%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Multi cap

Strategy

Index tracking

Sector

Health care

Focus

Pharmaceuticals

Index tracked

Dynamic Pharmaceutical Intellidex Index

What it actually holds

By weight

Concentration

Top 10 holdings = 51.6% of fundmoderately concentrated

Invesco Private Prime Fund

6.2%

Gilead Sciences, Inc.

5.7%

Johnson & Johnson

5.6%

Merck & Co., Inc.

5.5%

Pfizer Inc.

5.3%

Amgen Inc.

5.2%

AbbVie Inc.

4.9%

Eli Lilly and Co.

4.9%

Abbott Laboratories

4.3%

Liquidia Corp.

4.0%

Asset allocation

Stocks

99.9%

Cash

0.1%

By sector

Healthcare

100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

16.6%Moderate

Year-on-year price swings

Max drawdown

-33.9%Severe

Worst peak-to-trough loss

Sharpe (3Y)

0.76Decent risk-adjusted returns

Sortino (3Y)

1.08Good downside protection

Where to buy

Listing

Exchange: NYSE Arca

Full fund details

Objective: Seeks to track the investment results of the Dynamic Pharmaceutical Intellidex Index.
Strategy: Invests at least 90% of total assets in securities of the Dynamic Pharmaceutical Intellidex Index, which includes common stocks of 30 U.S. pharmaceutical companies across various segments.
Inception date: June 23, 2005
Fund family: Invesco